Class 2 Medicines recall: Ranitidine Effervescent Tablets 150mg and 300mg

Class 2 Medicines recall: Ranitidine Effervescent Tablets 150mg and 300mg

October 17, 2019

Class 2 MHRA medicines recall – Ranitidine Effervescent Tablets 150mg and 300mg (Teva UK Limited trading as ratiopharm GmbH)

Drug alert number: EL (19)A/27

Date issued: 17 October 2019

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

Ranitidine Effervescent Tablets 150mg and 300mg (Teva UK Limited trading as ratiopharm GmbH)

Teva UK Ltd is recalling all unexpired stock of the following products from pharmacies as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential:

Ranitidine Effervescent Tablets 150mg – PL 15773/066

Batch Number Expiry Date Pack Size First Distributed
17007672 30/04/2020 1 x 60 01/09/2017
17011546 30/06/2020 1 x 60 19/12/2017
17017838 30/09/2020 1 x 60 28/03/2018
18001231 31/12/2020 1 x 60 15/08/2018
18006590 31/03/2021 1 x 60 20/11/2018
18006591 31/03/2021 1 x 60 03/12/2018
18010644 30/06/2021 1 x 60 06/11/2018
18010645 30/06/2021 1 x 60 05/06/2019

Ranitidine Effervescent Tablets 300mg – PL 15773/067

Batch Number Expiry Date Pack Size First Distributed
17001878 31/01/2020 1 x 30 27/06/2017
17011702 30/06/2020 1 x 30 09/07/2018

Advice for healthcare professionals

  • Please stop supplying the above listed products immediately. All remaining stock should be quarantined and returned to your supplier using your supplier’s approved process.
  • Advise patients not to stop taking their medication as the health risk of discontinuing the medicine is higher than the potential risk presented by the contaminant. A treatment review is not necessary until the next routine appointment.

Full drug alert can be viewed here.

For stock control enquiries please contact Teva Customer Solutions team on 0800 590502 or customer.services@tevauk.com
For medical information enquiries please contact Teva UK Medical Information Department on 0207 540 7337 or UK.Safety@tevauk.com



Posted in: , ,


More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...